findmyKOL

Nancy Kemeny, MD

Enriched profile

Emeritus Member, Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine (retired September 2023 after 45+ years on staff) · Memorial Sloan Kettering Cancer Center

ORCIDNPI
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyMedical OncologyFocusHepatocellular Carcinoma Treatment and Prognosis+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceverified 2026Payments2023–2025NIH funding1987–2001

Nancy Kemeny is Emeritus Member, Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine (retired September 2023 after 45+ years on staff) at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 612 publications with 37,022 citations (h-index 99); ClinicalTrials.gov lists 10 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Nancy E. Kemeny, MD, is Emeritus Member, Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine (retired September 2023 after 45+ years on staff) at Memorial Sloan Kettering Cancer Center. The public record shows 612 publications with 37,022 citations (h-index 99), centered on Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies, Cholangiocarcinoma and Gallbladder Cancer Studies. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 3 companies, 2 NIH-funded awards (1987–2001).

  • Most recent indexed publication: 2025 · JCO precision oncology
  • Top research focus: Hepatocellular Carcinoma Treatment and Prognosis
  • 10 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Colorectal Cancer10 trialsRectal Neoplasms10 trialsHepatobiliary Cancer2 trialsColonic Neoplasms2 trialsPancreatic Cancer1 trialBladder / Urothelial Cancer1 trialGastroesophageal Cancer1 trialStomach Neoplasms1 trialEsophageal Neoplasms1 trialLiver Neoplasms1 trialAnus Neoplasms1 trialGallbladder Neoplasms1 trialBile Duct Neoplasms1 trialCarcinoid Tumor1 trialNeoplasm Metastasis1 trialCholangiocarcinoma1 trial

Research focus

OpenAlex concept fingerprint
Hepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and StudiesCholangiocarcinoma and Gallbladder Cancer StudiesGenetic factors in colorectal cancerPancreatic and Hepatic Oncology Research

Drugs & molecules

across trials, industry payments and publications
Lumakrasgeneric · SotorasibClinical trialsIndustry payments1PublicationsVectibixgeneric · PanitumumabClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Memorial Sloan Kettering Cancer CenterClinical trials9Industry paymentsIntera Oncology, IncClinical trialsIndustry payments7Alliance for Clinical Trials in OncologyClinical trials1Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
612publications

Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.

37,022citations

Total citations across indexed works.

99h-index

Hirsch index (OpenAlex). i10-index 299.

Clinical & industry

trials, payments and federal funding
10clinical trials

Investigator role on registered studies.

View trials
3companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
2NIH grants · 1987–2001

Federally funded research awards.

View funding

Industry payments

Updated 27 Aug 2026

3 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    100%
    Bile Acid100%
    Ursodiol100%
    Part D<11 patients
Where care is delivered (Part B), 20230% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

2 NIH research awards on record, funded 19872001 per NIH RePORTER. The latest:

9 more award records behind the reveal.Reveal →

Congress activity

Updated 27 Aug 2026

65 congress contributions (2004–2024) across AACR, ASCO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/nancy-kemeny-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/scientific-contributions/Nancy-Kemeny-39306104

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • LinkedIn

    linkedin.com/in/nancy-kemeny-2474b015

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • Other

    mskcc.cloud-cme.com/default.aspx

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.cloud-cme.com
  • X / Twitter

    x.com/InteraOncology/status/1730634026719859108

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com
  • LinkedIn

    LinkedIn: "Professor at MSKCC" (nancy-kemeny-2474b015)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Medicine and Dentistry of New Jersey (1971), one directory (Healthgrades) lists Seton Hall University instead; likely refers to the same institution's earlier name/lineage, unresolved

    1971
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com
  • BA

    University of Pennsylvania

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com
  • Residency

    Internal Medicine, St. Luke's-Roosevelt Hospital

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com
  • Fellowship

    Internal Medicine/Oncology, Memorial Sloan Kettering Cancer Center

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com
  • Board Certified

    Internal Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sharecare.com
  • Board Certified

    Medical Oncology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sharecare.com

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Professor Emerita of Medicine

    Weill Cornell Medical College (formerly Assistant/Associate/full Professor in the Department of Medicine at Cornell University/Weill Cornell during active career)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vivo.weill.cornell.edu

Media & interviews

press, podcasts and appearances
2 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.